Lipid nanoparticles (LNPs), composed of ionized lipids, helper lipids, and cholesterol,
provide general therapeutic effects by facilitating intracellular transport and avoiding …

Breast cancer is the second leading cancer-related disease as the most common non-
cutaneous malignancy among women. Curative options for breast cancer are limited …

Cancer is a severe disease that results in death in all countries of the world. A nano-based
drug delivery approach is the best alternative, directly targeting cancer tumor cells with …

One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …

Globally, breast cancer is one of the most prevalent diseases, inducing critical intimidation to
human health. Lipid-based nanomaterials have been successfully demonstrated as drug …

Cancer nanotechnology is a new field of interdisciplinary research cutting across biology,
chemistry, engineering, and medicine, aiming to lead to major advances in cancer treatment …

Breast cancer is the most common type of cancer with the highest morbidity and mortality
rates in women worldwide. Recent efforts to improve the current antitumor therapies have …

Breast cancer is the most frequently diagnosed cancer among women. Breast cancer is also
the key reason for worldwide cancer-related deaths among women. The application of small …

Despite all the advances seen in recent years, the severe adverse effects and low specificity
of conventional chemotherapy are still challenging problems regarding cancer treatment …

Drug delivery systems have opened new avenues to improve the therapeutic effects of
already-efficient molecules. Particularly, Solid Lipid Nanoparticles (SLNs) have emerged as …